M/16/055 - Joint venture UPMC (Ireland) & Bon Secours Health System [2016] IECompA m16055 (9 December 2016)

M/16/055 - Joint venture UPMC (Ireland) & Bon Secours Health System [2016] IECompA m16055 (9 December 2016)

The Competition and Consumer Protection Commission determined that the proposed joint venture would not substantially lessen competition in any market for goods or services in the State and therefore cleared the transaction under Phase 1 review.

Parties
Party: UPMC (Ireland) Limited; Party: Bon Secours Health System Limited; Joint Venture Entity: Druid Stone Limited (to be renamed Cork Radiation Oncology Associates Limited)
Jurisdiction
Ireland
Judgment Date
09 December 2016
Procedural Posture
Merger Control / Phase 1 Clearance
Outcome
cleared
Legal Topics
Merger Control, Joint Venture, Healthcare Services
Competition Law Merger Control Joint Venture Healthcare Services

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

UPMC (Ireland) Limited

Party

Bon Secours Health System Limited

Party

Druid Stone Limited (to be renamed Cork Radiation Oncology Associates Limited)

Joint Venture Entity

Procedural Posture

Merger Control / Phase 1 Clearance

Legal Issues

  1. 1 Whether the proposed joint venture between UPMC (Ireland) Limited and Bon Secours Health System Limited for the provision of radiotherapy services at Bon Secours Hospital, Cork, should be cleared under Irish competition law

Ratio Decidendi

The Competition and Consumer Protection Commission determined that the proposed joint venture would not substantially lessen competition in any market for goods or services in the State and therefore cleared the transaction under Phase 1 review.

Court Disposition

cleared

Orders

  • The proposed joint venture between UPMC (Ireland) Limited and Bon Secours Health System Limited, to be established as Druid Stone Limited (to be renamed Cork Radiation Oncology Associates Limited), is cleared under Phase 1 merger review.